Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jan 27, 2023; 15(1): 105-113
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105
Group | n | Before treatment | After 1 mo of treatment | After 3 mo of treatment |
Study group | 49 | 6.31 ± 2.00 | 4.11 ± 1.42 | 2.20 ± 1.04 |
Control group | 49 | 6.14 ± 1.89 | 4.78 ± 1.50 | 2.81 ± 0.95 |
t value | 0.432 | -2.271 | -3.031 | |
P value | 0.666 | 0.025 | 0.003 |
- Citation: Wang L, Huang K, Zhang Y, Wu YF, Yue ZD, Fan ZH, Liu FQ, Li YW, Dong J. Short-term efficacy assessment of transarterial chemoembolization combined with radioactive iodine therapy in primary hepatocellular carcinoma. World J Gastrointest Surg 2023; 15(1): 105-113
- URL: https://www.wjgnet.com/1948-9366/full/v15/i1/105.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.105